Jul 2, 2013

The paradigm dispute in medicine -Bibliography

Copy rights of the content in this article are with the respectable Author.
-  The paradigm dispute in medicine (H. L. Coulter)

American Medical Association. Council on Pharmacy and Chemistry. Committee on Research. "A Status Report on 'Krebiozen.'" JAMA l47:9 (October 27, 1951), 864-873.
 Bailey, Herbert. K -Krebiozen-Key to Cancer? New York: Hermitage House, 1955.
 Burzynski Research Institute Website on Internet (http://cancermed. com/bri. htm)
 Coulter, Harris L. Divided Legacy: A History of the Schism in Medical Thought, Volume III. Homoeopathy and the American Medical Association. Second Edition. Berkeley: North Atlantic Books and Homoeopathic Educational Services, 1982.
 Davenas, E., F. Beauvais, J. Amara, M. Oberbaum, B. Robinzon, A. Miadonna, A. Tedeschi, B. Pomeranz, P. Fortner, P. Belon, J. Sainte-Laudy, B. Poitevin, and J. Benveniste. "Human Basophil Degranulation Triggered by Very Dilute Antiserum Against IgE." Nature 333 (June 30, 1988), 816-818.
 "Dr. Jacques Benveniste Replies." Nature 334 (July 28, 1988), 191.
 Everson, T.C.  and Warren Cole. Spontaneous Regression of Cancer: A Study and Abstract of Reports in the Medical Literature and of Personal Communications Concerning Spontaneous Regression of Malignant Disease. Philadelphia: W.C.  Saunders, 1966.
 "Explanation of Benveniste." Nature 334 (July 28, 1988), 285-286.
 Final Report of Krebiozen Investigating Commission of The General Assembly of the State of Illinois. June 30, 1955.
 "FDA Mistaken, Krebiozen Not Creatine: NCI Judgment of Cases Biased and Irrelevant: Evidence Justified Fair Test Now. Speeches of Hon. Paul H. Douglas of Illinois in the Senate of the United States."
 Congressional Record. Proceedings and Debates of the 88th Congress, First Session. September-December, 1963.
 Fottorino, Eric. "La Memoire de l'Eau. I. Du Reve au Soupcon; II. Le Temps des Passions; III. Une Verite Hautement Diluee; IV. 'La Memoire de l'Eau' en Debat." Le Monde (Paris), January 21, 22, 23, and February 8, 1997.
 Ivy, Andrew C. "Biology of Cancer." Science (November 14, 1947), 455-460.
 Kokish, John. "The Krebiozen Story." Denver Post, January 5, 6,7,8,9, 10,12,13, 1964.
 Langer, Elinor. "Krebiozen: A Dozen Years After Introduction, Controversy over Cancer Treatment Still Flares." Science 140 (June 21, 1963), 1294-1296; "Krebiozen: Nearly a Decade of Controversy Spent in Pursuit of 'Fair,' Government-Sponsored Test." Science 140 (June 28, 1963), 1383-`1385; "Krebiozen: FDA Deadline Brings New, But Not the Final, Episode in Controversy over Cancer Drug." Science 141 (July 5, 1963), 31-33.
 Maddox, J. J. Randi, W. W. Stewart. "'High-dilution' experiments a delusion." Nature 334 (July 28, 1988), 287-290.
 Medical Society of the County of Erie. "Dear Doctor Letter" (January 7, 1964) advising that "the prescription or dispensing by a physician of Krebiozen or other secret medicines or remedial agents, of which he does not know the composition, is unethical under any circumstances."
 Moss, Ralph W. The Cancer Industry: Unravelling the Politics. New York: Paragon House, 1989.
 National Committee to Review Current Procedures For Approval of New Drugs for Cancer and AIDS. Meeting of September 13, 1989, p. 170. Statement by Louis Lasagna, MD (unpublished).
 Regelson, William. "The 'Grand Conspiracy' Against the Cancer Cure." JAMA 243:4 (January 25, 1980), 337-339.
 Staehlin, Isadora. "Homoeopathy: Real Medicine or Empty Promises?" FDA Consumer (December, 1996).
 Ward, Patricia Spain. "'Who Will Bell the Cat?' Andrew C. Ivy and Krebiozen." Bulletin of the History of Medicine 58 (1984), 228-52.
 Wiemann, B. And C.O. Starnes. "Coley's Toxins, Tumor Necrosis Factor and Cancer Research: A Historical Perspective." Pharmac. Ther. 64 (1994), 529-564.
 Young, Frank. Statement to National Committee to Review Current Procedures for Approval of New Drugs for Cancer and AIDS, Bethesda, Maryland, January 4, l989 (unpublished). 


Post a Comment

Leave Your Valuable Suggestions and Comments.